
CMS said the Biden-era support will expire at year-end, with 2027 Part D pricing details due in September and officials saying most beneficiaries will see premium increases of less than $10.
The Trump administration said it will let a Biden-era Medicare Part D premium subsidy program expire at the end of 2026, arguing the support benefited insurers more than enrollees and is no longer needed. The temporary aid is expected to provide insurers with about $3.6 billion this year to cushion premium increases. Medicare Part D, the prescription drug benefit offered through private plans, was reworked under former President Biden to add a $2,000 annual cap on out-of-pocket drug spending and allow Medicare to negotiate prices for some high-cost drugs. CMS said it expects to release new monthly pricing details in mid- to late-September. For 2027, the national average monthly bid amount will be $296.05 and the base beneficiary premium will be $41.33. Dr. Mehmet Oz, the current administrator of CMS, said premiums will rise by less than $10 for most Medicare recipients, while some may see lower premiums. Roughly 25 million Americans are enrolled in standalone Part D plans.